Literature DB >> 35559420

YY1 as a promoter regulating the circ_0001946/miR-671-5p/EGFR axis to promote chemotherapy resistance in breast cancer cells.

Ge Gao1, Xiaoyan Li2, Jiabeini Zhang3, Hong Yu3.   

Abstract

OBJECTIVE: To investigate the mechanism of circ_0001946 activated by transcription factor Yin Yang 1 (YY1), targeting miR-671-5p to regulate epidermal growth factor receptor (EGFR) and thereby participating in the chemotherapy resistance of breast cancer (BC) cells.
METHODS: Circ_0001946, which is differentially expressed in BC, was screened using gene expression omnibus. Dual luciferase assay and RNA immunoprecipitation were conducted to verify the relationship among circ_0001946/miR-671-5p/EGFR. A ChIP test confirmed that YY1 can be used as a transcription factor of circ_0001946 to specifically bind to its promoter. The expression of circ_0001946/miR-671-5p/EGFR regulatory axis in BC tissues and cell lines were evaluated using qRT-PCR. As for in vitro experiments, tamoxifen was used to establish a drug-resistant BC cell model. The effects of the regulatory axis on the proliferation, invasion and apoptosis of BC cells were studied using CCK-8, Transwell invasion assay and Annexin V-FITC/PI staining, so as to evaluate its effect on the sensitivity of BC cells to tamoxifen.
RESULTS: Circ_0001946 showed an abnormally high expression in BC tissues and tamoxifen resistant cells and was up-regulated in an IC50-dependent manner (both P<0.05). Circ_0001946 was activated by YY1 in drug-resistant BC cells. Knockdown of circ_0001946 significantly inhibited the proliferation, invasion and promoted apoptosis of drug-resistant BC cells (all P<0.05). Overexpression of circ_0001946 promoted the proliferation and invasion of drug-resistant BC cells and hindered their apoptosis, which could be partially reversed by miR-671-5p mimics (all P<0.05). EGFR has been proven to be a downstream target gene of miR-671-5p. A knockdown of EGFR improved the malignant biological behavior of drug-resistant BC cells, which could be partially eliminated by overexpression of circ_0001946 (all P<0.05).
CONCLUSION: Circ_0001946 absorbs miR-671-5p to target EGFR to promote the growth and malignant invasion of drug-resistant BC cells, thereby increasing the resistance to tamoxifen. This effect of circ_0001946 may be achieved by transcriptional activation of YY1. AJTR
Copyright © 2022.

Entities:  

Keywords:  circ_0001946; epidermal growth factor receptor (EGFR); miR-671-5p; tamoxifen

Year:  2022        PMID: 35559420      PMCID: PMC9091114     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  27 in total

1.  Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.

Authors:  Q Huang; Y-Y Wu; S-J Xing; Z-W Yu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-06       Impact factor: 3.507

2.  Circular RNA circ_0084927 regulates proliferation, apoptosis, and invasion of breast cancer cells via miR-142-3p/ERC1 pathway.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.

Authors:  Kathryn J Ruddy; Lindsey R Sangaralingham; Holly Van Houten; Somaira Nowsheen; Nicole Sandhu; Javid Moslehi; Heather Neuman; Ahmedin Jemal; Tufia C Haddad; Anne H Blaes; Hector R Villarraga; Carrie Thompson; Nilay D Shah; Joerg Herrmann
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-02-28

4.  Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.

Authors:  Qiuli Wang; Dong Liang; Peng Shen; Yang Yu; Yuan Yan; Wei You
Journal:  Transl Oncol       Date:  2021-05-20       Impact factor: 4.243

5.  Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via miR-197-3p/HIPK3 axis in breast cancer.

Authors:  Hongjuan Li; Qing Li; Shan He
Journal:  World J Surg Oncol       Date:  2021-02-03       Impact factor: 2.754

6.  Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression.

Authors:  Aixia Hu; Fan Hong; Daohong Li; Yuwei Jin; Lingfei Kon; Ziguang Xu; Hui He; Qi Xie
Journal:  J Transl Med       Date:  2021-03-02       Impact factor: 5.531

7.  The interaction effects of FEN1 rs174538 polymorphism and polycyclic aromatic hydrocarbon exposure on damage in exon 19 and 21 of EGFR gene in coke oven workers.

Authors:  Siqin Chen; Yuefeng He; Maosheng Yan; Yun Zhou; Qinghua He; Jingwen Tan; Binyao Yang
Journal:  Environ Sci Pollut Res Int       Date:  2021-06-23       Impact factor: 4.223

8.  YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.

Authors:  Zhen Yang; Hongjian Ding; Zhiyu Pan; Huaqing Li; Junbin Ding; Qian Chen
Journal:  Cancer Biol Ther       Date:  2021-03-08       Impact factor: 4.742

9.  Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.

Authors:  Ziqi Peng; Boyang Xu; Feng Jin
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis.

Authors:  Wei Zhong; Lei Bao; Yangyi Yuan; Yanzhi Meng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.